These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2964264)

  • 1. Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time.
    Noguchi S; Miyauchi K; Nishizawa Y; Koyama H
    Cancer; 1988 Apr; 61(7):1345-9. PubMed ID: 2964264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
    Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
    Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
    Byrne MJ; Gebski V; Forbes J; Tattersall MH; Simes RJ; Coates AS; Dewar J; Lunn M; Flower C; Gill PG; Stewart J
    J Clin Oncol; 1997 Sep; 15(9):3141-8. PubMed ID: 9294477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.
    Gundersen S; Kvinnsland S; Lundgren S; Klepp O; Lund E; Børmer O; Høst H
    Breast Cancer Res Treat; 1990 Nov; 17(1):45-50. PubMed ID: 2151369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of estrogen receptor by tamoxifen in human breast cancer.
    Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1993 Feb; 71(4):1266-72. PubMed ID: 8382104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor expression in endometria from women treated with tamoxifen.
    Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
    Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tamoxifen-induced progesterone receptors in breast tumors].
    Tsyrlina EV; Semiglazov VF; Nurgaziev KSh; Ivanova OA
    Vopr Onkol; 1991; 37(9-10):916-21. PubMed ID: 1842650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer.
    Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1993 Jul; 72(1):131-6. PubMed ID: 8508397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.
    Fisher B; Redmond C; Brown A; Fisher ER; Wolmark N; Bowman D; Plotkin D; Wolter J; Bornstein R; Legault-Poisson S
    J Clin Oncol; 1986 Apr; 4(4):459-71. PubMed ID: 2856857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroid hormone receptors and cellular proliferative activity following the short-term use of tamoxifen and chlorotrianisene in breast cancer].
    Vyshinskaia GV; Murav'eva NI; Shelsputina ZF; Kuz'mina ZV; Nikolaeva TG
    Eksp Onkol; 1985; 7(5):66-8. PubMed ID: 4065023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormone dependence of malignant ovarian tumors--an in vitro model].
    Schieder K; Bieglmayer C; Kölbl H
    Geburtshilfe Frauenheilkd; 1989 May; 49(5):437-41. PubMed ID: 2544477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer.
    Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
    Cancer; 1990 Mar; 65(6):1375-9. PubMed ID: 2137722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients.
    Beltrán M; Alonso MC; Ojeda MB; Izquierdo A; Ferrer J; Picó C; Anglada L; Catalán G; Batiste-Alentorn E; Tusquets I
    Ann Oncol; 1991 Jul; 2(7):495-9. PubMed ID: 1832944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
    Lim YC; Desta Z; Flockhart DA; Skaar TC
    Cancer Chemother Pharmacol; 2005 May; 55(5):471-8. PubMed ID: 15685451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progesterone receptors of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Shapira J; Beyth Y; Bernheim J; Tepper R; Cordoba M; Altaras MM
    Gynecol Obstet Invest; 1998; 45(2):126-31. PubMed ID: 9517806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study.
    De Lena M; Tommasi S; Schittulli F; Lorusso V; Paradiso A
    Tumori; 1990 Apr; 76(2):190-5. PubMed ID: 2139523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
    Mouridsen HT; Palshof T; Rose C
    Recent Results Cancer Res; 1980; 71():169-77. PubMed ID: 6988913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.
    Osborne CK; Von Hoff DD; Mullins K
    Breast Cancer Res Treat; 1985; 6(3):229-35. PubMed ID: 2936413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer.
    Nemoto T; Patel JK; Rosner D; Dao TL; Halvorson H
    J Surg Oncol; 1989 Aug; 41(4):226-9. PubMed ID: 2526907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.